Drug Repositioning Efforts by Nonprofit Foundations

20120 citationsOther

Authors

Donald E. Frail · AstraZeneca (United States)

Louis J. DeGennaro · Leukemia and Lymphoma Society

Aaron D. Schimmer · Ontario Institute for Cancer Research

James M. Kasper · Leukemia and Lymphoma Society

Richard C. Winneker · Leukemia and Lymphoma Society

Todd Sherer · Michael J. Fox Foundation

Alison Urkowitz

Abstract

This chapter contains sections titled: Introduction Repositioning of Drugs for Hematological Malignancies: Perspective from the Leukemia & Lymphoma Society Repositioning Drugs for Parkinson's Disease: Perspective from the Michael J. Fox Foundation Repositioning Drugs for Polycystic Kidney Disease: Perspectives from the Polycystic Kidney Disease Foundation References

Topics & Keywords

Lysosomal Storage Disorders Research Parkinson's Disease Mechanisms and Treatments Folate and B Vitamins Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

DOI: 10.1002/9781118274408.ch12